Kedokteran & Kesehatan editorial
Open AccessOA2024
Epidemiology, Pathophysiology and Imaging of Atherosclerotic Intracranial Disease
Intracranial atherosclerotic disease (ICAD) is a leading global cause of stroke, with high recurrence rates in severe stenosis. This digest summarizes its epidemiology, pathophysiology, and the role of lumen-based and vessel wall imaging.
Li-Hui Chen; Antonio Spagnolo-Allende; Dixon Yang; Ye Qiao; J. Gutierrez· Stroke· 2024· DOI 10.1161/STROKEAHA.123.043630
The core problem
Intracranial atherosclerotic disease (ICAD) is one of the most common causes of stroke worldwide. Among people with stroke, those of East Asian descent and non-White populations in the United States have a higher burden of ICAD-related stroke compared with Whites of European descent. Disparities in the prevalence of asymptomatic ICAD are less marked than with symptomatic ICAD. In addition to stroke, ICAD increases the risk of dementia and cognitive decline, magnifying its societal burden. The risk of stroke recurrence among patients with ICAD-related stroke is highest among those with confirmed stroke and stenosis ≥70%. In fact, the 1-year recurrent stroke rate of >20% among those with stenosis >70% is one of the highest rates among common causes of stroke.
Innovation
This review synthesizes evidence from epidemiological studies, pathophysiological investigations, and imaging research to provide a comprehensive overview of ICAD. The authors examined data on prevalence, stroke recurrence, and mechanisms of stroke, and evaluated the utility of various imaging modalities, including lumen-based techniques (computed tomographic angiography, magnetic resonance angiography, digital subtraction angiography) and newer technologies such as high-resolution vessel wall magnetic resonance imaging (HR-VWI). The review also assessed the potential of quantitative magnetic resonance angiography, computed tomographic angiography, magnetic resonance perfusion, and transcranial Doppler for risk stratification beyond the degree of stenosis.
Introduction
Intracranial atherosclerotic disease (ICAD) is one of the most common causes of stroke worldwide. Among people with stroke, those of East Asian descent and non-White populations in the United States have a higher burden of ICAD-related stroke compared with Whites of European descent. Disparities in the prevalence of asymptomatic ICAD are less marked than with symptomatic ICAD. In addition to stroke, ICAD increases the risk of dementia and cognitive decline, magnifying its societal burden. The risk of stroke recurrence among patients with ICAD-related stroke is highest among those with confirmed stroke and stenosis ≥70%. In fact, the 1-year recurrent stroke rate of >20% among those with stenosis >70% is one of the highest rates among common causes of stroke.
Why it matters
The authors highlight that ICAD imposes a substantial societal burden due to its high prevalence, association with cognitive decline, and elevated risk of recurrent stroke, particularly in severe stenosis. The disparities in ICAD burden suggest genetic, environmental, and healthcare access factors that warrant further investigation. The pathophysiological heterogeneity of ICAD—encompassing plaque rupture, embolism, hemodynamic failure, and branch occlusion—implies that tailored therapeutic strategies may be necessary. While lumen-based imaging remains the cornerstone of diagnosis, HR-VWI offers promise in differentiating ICAD from other arteriopathies. However, the role of advanced hemodynamic and perfusion imaging in risk stratification beyond stenosis severity is not yet established. Future research should focus on validating these techniques and addressing disparities in ICAD outcomes.
Who should read this
Pembaca Research Digest dan praktisi rumpun ini.
Opening member content…